All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
SAN FRANCISCO – Despite growing appreciation for many benefits of personalized medicine, earning it new attention in health care institutions and Washington, progress in the field continues to be decidedly mixed, according to speakers at the Molecular Medicine Tri-Con meeting this week.